Anzeige
Mehr »
Login
Sonntag, 28.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Fokus auf Nurexone: High-Level Biotech im Pennystock-Kleid!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Übersicht Suchergebnisse zum Thema E. W. SCRIPPS

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
DiE.W. Scripps exploring sale of Bounce TV - report1
DiEW Scripps exploring sale of Black-culture broadcast network Bounce TV1
DiDirecTV Launches New Streaming Channels from Cineverse and Scripps Networks2
MoThe CW Will Not Renew Affiliations with Scripps Stations in Seven Markets-
18.04.Scripps News Inks Deal with Ad Fontes Media to Rate Content for Reliability and Bias-
09.04.Scripps Safe, Inc. - S-1/A, General form for registration of securities-
08.04.Scripps News Debuts Lineup Of New Programs-
26.03.E.W. SCRIPPS Co - 8-K, Current Report1
28.02.Scripps appoints Kate O'Brian to the new role of president of News1
24.02.The E.W. Scripps Company (SSP) Q4 2023 Earnings Call Transcript3
24.02.Earnings call: E.W. Scripps exceeds Q4 cash flow expectations1
23.02.E.W. SCRIPPS Co - 10-K, Annual Report1
23.02.E W Scripps Co reports results for the quarter ended in December - Earnings Summary3
23.02.E.W. SCRIPPS Co - 8-K, Current Report3
23.02.E.W. Scripps EPS of -$3.17, revenue of $615.77M beats by $13.77M1
23.02.The E.W. Scripps Company: Scripps reports Q4 2023 financial results631CINCINNATI, Feb. 23, 2024 /PRNewswire/ -- The E.W. Scripps Company (NASDAQ: SSP) delivered $616 million in revenue for the fourth quarter of 2023. Loss attributable to the shareholders of Scripps...
► Artikel lesen
22.02.E.W. Scripps Q4 Earnings Preview1
09.02.Wall Street is overreacting to new sports joint venture, says EW Scripps CEO1
06.02.Scripps Research: Calibr-Skaggs announces expansion of option and license agreement with AbbVie to develop novel cell therapies for solid tumors and autoimmune diseases125AbbVie to maintain exclusive access to Calibr-Skaggs' switchable CAR-T (sCAR-T) platform to develop novel cell therapy candidates against solid tumor targets identified by AbbVie AbbVie also has the...
► Artikel lesen
05.02.Scripps Hires Tony Song to Lead National Network Sales and Advanced TV-
Seite:  Weiter >>